Webinar: QIAGEN’s new dPCR portfolio – overcoming the current throughput, speed and usability bottlenecks in digital PCR

Digital PCR (dPCR) is a highly viable solution for copy number variation (CNV) detection, rare mutation detection and quantification, validation of NGS results, and applications alike. It offers significant advantages over quantitative PCR (qPCR) with regards to precision, reproducibility, and sensitivity, coupled with the ability to obtain absolute quantitative results without the need for standard curves. That is why, over the last years, many researchers have come to use dPCR, resulting in over 4500 publications until the previous year.

However, currently available solutions are either very complex to operate, or lack a scalability option for users with variable throughput and flexible workflow needs. Unlike current systems relying on droplet generation, QIAGEN’s offering of fully integrated walkaway instrument options and multiple plate configurations with increased partitions can potentially solve throughput, speed, and usability challenges.

In this webinar, we’ll discuss:

• What improvements does QIAGEN’s dPCR solution offer over existing systems
• First insights into our entire dPCR product portfolio
• The menu of dPCR assays and their availability roadmap

Speakers:

Dr. Gerald Schock, Associate Director digital PCR instrumentsQIAGEN GmbH

Dr. Michael Bussmann, Associate Director digital PCR assays, QIAGEN GmbH